Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Breast cancer in men]

R Palade1, D Vasile, M Grigoriu

  • 1Clinica Chirurgie I, S.U.B.

Chirurgia (Bucharest, Romania : 1990)
|May 1, 1997
PubMed
Summary

Male breast cancer (MBC) is rare, accounting for 1.3% of breast cancer cases. This study highlights MBC

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the safety of high-intensity focused ultrasound treatment for rectal endometriosis: results from a French prospective multicentre study including 60 patients.

Human reproduction (Oxford, England)·2024
Same author

Treatment techniques for rectovaginal fistulas after low rectal resection for deep endometriosis.

Techniques in coloproctology·2024
Same author

First-line surgery vs first-line ART to manage infertility in women with deep endometriosis without bowel involvement: A multi-centric propensity-score matching comparison.

European journal of obstetrics, gynecology, and reproductive biology·2022
Same author

Resection of a deep endometriosis nodule of the bladder (with video).

Journal of visceral surgery·2022
Same author

What to choose and why to use - a critical review on the clinical relevance of rASRM, EFI and Enzian classifications of endometriosis.

Facts, views & vision in ObGyn·2022
Same author

Corrigendum. Nonvisualized palpable bowel endometriotic satellites.

Human reproduction (Oxford, England)·2021

Area of Science:

  • Oncology
  • Men's Health
  • Surgical Pathology

Context:

  • Male breast cancer (MBC) is a rare malignancy, comprising approximately 1.3% of all breast cancer diagnoses.
  • Gynecomastia was identified as a potential risk factor in two observed cases.
  • Diagnostic presentation varied, with tumoral masses behind the areola in 90% of cases and bloody nipple discharge in one case.

Purpose:

  • To analyze the clinical characteristics, diagnosis, treatment, and prognosis of male breast cancer.
  • To evaluate the incidence and presentation of MBC within a specific patient cohort over a 20-year period.

Summary:

  • Ten cases of male breast cancer were documented over 20 years.
  • Clinical signs included tumoral masses, nipple discharge, and palpable adenopathy, with staging ranging from I to IV.
  • Diagnosis was confirmed via radiology, scintigraphy, and pathology, with surgical mastectomy being the primary treatment.

Impact:

  • Male breast cancer exhibits a poor prognosis, with a 5-year survival rate of 50% for stages I and II, and significantly lower for stages III and IV.
  • This study underscores the challenges in MBC diagnosis and treatment, emphasizing the need for continued research and awareness.
  • Outcomes indicate a critical need for early detection and aggressive management strategies for male breast cancer patients.

Related Experiment Videos